Logo image of PCT

PURECYCLE TECHNOLOGIES INC (PCT) Stock Fundamental Analysis

NASDAQ:PCT - Nasdaq - US74623V1035 - Common Stock - Currency: USD

13.28  +0.66 (+5.23%)

After market: 13.3001 +0.02 (+0.15%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to PCT. PCT was compared to 85 industry peers in the Chemicals industry. PCT has a bad profitability rating. Also its financial health evaluation is rather negative. PCT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

PCT had negative earnings in the past year.
In the past 5 years PCT always reported negative net income.
In the past 5 years PCT always reported negative operating cash flow.
PCT Yearly Net Income VS EBIT VS OCF VS FCFPCT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -100M -200M -300M

1.2 Ratios

PCT's Return On Assets of -24.73% is on the low side compared to the rest of the industry. PCT is outperformed by 84.71% of its industry peers.
PCT has a Return On Equity of -81.73%. This is amonst the worse of the industry: PCT underperforms 85.88% of its industry peers.
Industry RankSector Rank
ROA -24.73%
ROE -81.73%
ROIC N/A
ROA(3y)-18.61%
ROA(5y)-13.78%
ROE(3y)-67.01%
ROE(5y)-44.56%
ROIC(3y)N/A
ROIC(5y)N/A
PCT Yearly ROA, ROE, ROICPCT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

PCT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PCT Yearly Profit, Operating, Gross MarginsPCT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, PCT has more shares outstanding
Compared to 5 years ago, PCT has more shares outstanding
PCT has a better debt/assets ratio than last year.
PCT Yearly Shares OutstandingPCT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
PCT Yearly Total Debt VS Total AssetsPCT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

PCT has an Altman-Z score of 0.83. This is a bad value and indicates that PCT is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.83, PCT is not doing good in the industry: 81.18% of the companies in the same industry are doing better.
PCT has a Debt/Equity ratio of 1.43. This is a high value indicating a heavy dependency on external financing.
PCT's Debt to Equity ratio of 1.43 is on the low side compared to the rest of the industry. PCT is outperformed by 75.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF N/A
Altman-Z 0.83
ROIC/WACCN/A
WACCN/A
PCT Yearly LT Debt VS Equity VS FCFPCT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

PCT has a Current Ratio of 0.55. This is a bad value and indicates that PCT is not financially healthy enough and could expect problems in meeting its short term obligations.
PCT has a Current ratio of 0.55. This is amonst the worse of the industry: PCT underperforms 92.94% of its industry peers.
A Quick Ratio of 0.45 indicates that PCT may have some problems paying its short term obligations.
PCT has a Quick ratio of 0.45. This is amonst the worse of the industry: PCT underperforms 90.59% of its industry peers.
Industry RankSector Rank
Current Ratio 0.55
Quick Ratio 0.45
PCT Yearly Current Assets VS Current LiabilitesPCT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for PCT have decreased strongly by -36.52% in the last year.
EPS 1Y (TTM)-36.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%112.82%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, PCT will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.16% on average per year.
Based on estimates for the next years, PCT will show a very strong growth in Revenue. The Revenue will grow by 211.54% on average per year.
EPS Next Y66.78%
EPS Next 2Y26.96%
EPS Next 3Y17.78%
EPS Next 5Y17.16%
Revenue Next Year1053.22%
Revenue Next 2Y525.56%
Revenue Next 3Y306.98%
Revenue Next 5Y211.54%

3.3 Evolution

PCT Yearly Revenue VS EstimatesPCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 500M 1B 1.5B 2B
PCT Yearly EPS VS EstimatesPCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PCT. In the last year negative earnings were reported.
Also next year PCT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PCT Price Earnings VS Forward Price EarningsPCT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PCT Per share dataPCT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

PCT's earnings are expected to grow with 17.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.96%
EPS Next 3Y17.78%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PCT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PURECYCLE TECHNOLOGIES INC

NASDAQ:PCT (8/4/2025, 8:00:00 PM)

After market: 13.3001 +0.02 (+0.15%)

13.28

+0.66 (+5.23%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-07 2025-08-07/amc
Inst Owners73.17%
Inst Owner Change-0.26%
Ins Owners2.79%
Ins Owner Change2.28%
Market Cap2.39B
Analysts75
Price Target14.28 (7.53%)
Short Float %22.97%
Short Ratio9.86
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)22.2%
Min EPS beat(2)-77.13%
Max EPS beat(2)121.52%
EPS beat(4)1
Avg EPS beat(4)-45.76%
Min EPS beat(4)-157.29%
Max EPS beat(4)121.52%
EPS beat(8)3
Avg EPS beat(8)-45.35%
EPS beat(12)5
Avg EPS beat(12)-32.22%
EPS beat(16)6
Avg EPS beat(16)-27.18%
Revenue beat(2)0
Avg Revenue beat(2)-78.25%
Min Revenue beat(2)-100%
Max Revenue beat(2)-56.51%
Revenue beat(4)0
Avg Revenue beat(4)-89.13%
Min Revenue beat(4)-100%
Max Revenue beat(4)-56.51%
Revenue beat(8)0
Avg Revenue beat(8)-94.56%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.69%
PT rev (3m)6.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.46%
EPS NY rev (1m)-1.92%
EPS NY rev (3m)32.46%
Revenue NQ rev (1m)1.25%
Revenue NQ rev (3m)-61.07%
Revenue NY rev (1m)1.18%
Revenue NY rev (3m)-26.79%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1511.15
P/FCF N/A
P/OCF N/A
P/B 10.02
P/tB 10.02
EV/EBITDA N/A
EPS(TTM)-1.17
EYN/A
EPS(NY)-0.62
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.01
BVpS1.32
TBVpS1.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.73%
ROE -81.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-18.61%
ROA(5y)-13.78%
ROE(3y)-67.01%
ROE(5y)-44.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.55
Quick Ratio 0.45
Altman-Z 0.83
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)3032.89%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%112.82%
EPS Next Y66.78%
EPS Next 2Y26.96%
EPS Next 3Y17.78%
EPS Next 5Y17.16%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year1053.22%
Revenue Next 2Y525.56%
Revenue Next 3Y306.98%
Revenue Next 5Y211.54%
EBIT growth 1Y-27.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year61.81%
EBIT Next 3Y43.18%
EBIT Next 5Y55.23%
FCF growth 1Y19.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-52.6%
OCF growth 3YN/A
OCF growth 5YN/A